Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / *W EXP 10/31/202
-
Total 13F shares
-
28,410
-
Share change
-
+28,410
-
Total reported value
-
$24,149
-
Price per share
-
$0.85
-
Number of holders
-
1
-
Value change
-
+$24,149
-
Number of buys
-
1
Institutional Holders of enGene Holdings Inc. - *W EXP 10/31/202 (ENGNW) as of Q4 2023
As of 31 Dec 2023,
enGene Holdings Inc. - *W EXP 10/31/202 (ENGNW) was held by
1 institutional
shareholder
that filed Form 13F with the SEC.
Together, they reported ownership of
28,410 shares.
The largest 10 holders included
BVF INC/IL, HIGHBRIDGE CAPITAL MANAGEMENT LLC, Omega Fund Management, LLC, Blue Owl Capital Holdings LP, Calamos Advisors LLC, COWEN AND COMPANY, LLC, AQR Arbitrage LLC, TENOR CAPITAL MANAGEMENT Co., L.P., D. E. Shaw & Co., Inc., and PERISCOPE CAPITAL INC..
This page lists
20
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.